US Medicare Insulin Demo Could Expand To Other Drugs

 
• By Derrick Gingery
Diabetes
Biosimilar insulin manufacturers are allowed to participate in the Part D demo, CMS Administrator Seema Verma said. • Source: Shutterstock

More from Medicare

More from Government Payers